R18-2016-e
Go-ahead for the Aurum “IMPAACT4TB” proposal
R17-2016-e
Go-ahead for the development of paediatric TB project proposals
R16-2016-e
Safer, more robust and less expensive antiretroviral first-line therapy (ADVANCE trial)
R15-2016-e
A randomised trial to compare dolutegravir+darunavir/r versu recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy
R14-2016-e
DolPHIN2: Dolutegravir in Pregnant HIV mothers and Neonates
R10-2016-e
P3: Private Sector Provision of PrEP
R13-2016-e
Accelerating access and integration of innovative point-of-care HIV technologies in national diagnostic programs – Phase 2b
R12-2016-e
E-market place for the procurement of public health commodities (wambo.org)
